@prefix dc1: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RAZbE3h1p3SuyXPWn1VLItHre4absKFdBoV82oZqHZlv8> .
@prefix sub: <http://purl.org/np/RAZbE3h1p3SuyXPWn1VLItHre4absKFdBoV82oZqHZlv8#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo .
}

sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_5419> bl:category bl:Disease .
  
  sub:association a rdf:Statement;
    rdf:object <http://purl.obolibrary.org/obo/DOID_5419>;
    rdf:predicate bl:treats;
    rdf:subject <https://identifiers.org/drugbank:DB08815>;
    rdfs:label "latuda is indicated for latuda is indicated for treatment of adult and adolescent patients 13 to 17 years with schizophrenia see clinical studies 14 1 monotherapy treatment of adult and pediatric patients 1 to 17 years with major depressive episode associated with bipolar i disorder bipolar depression see clinical studies 14 2 14 2 adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder bipolar depression see clinical studies 14 2 latuda is an atypical antipsychotic indicated for the treatment of schizophrenia in adults and adolescents 13 to 17 years 1 14 1 depressive episode associated with bipolar i disorder bipolar depression in adults and pediatric patients 1 to 17 years as monotherapy 1 14 2 depressive episode associated with bipolar i disorder bipolar depression in adults as adjunctive therapy with lithium or valproate 1 14 2";
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
    bl:provided_by <https://w3id.org/um/NeuroDKG>;
    bl:relation schema:TreatmentIndication .
  
  <https://identifiers.org/drugbank:DB08815> bl:category bl:Drug .
}

sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}

sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
    npx:hasSignature "XKe52B4gw8vEjt34/FC8hCOq2qMt/1Xbv6SFygg9Jooy7jFra54sVdtVliOvtQfKmwYkJGyyc+IKB9J7Yj1ulcsaMtrGasAO5rCXjTFdtONJx2VSgaQMSznKu1WnSgYbFiXzdrGvCUz4mAsRcW/vTzEoT3tQn/J5dR3ZGg3+99g=";
    npx:hasSignatureTarget this: .
  
  this: dc1:created "2021-07-03T12:23:18.699+02:00"^^xsd:dateTime;
    dc1:creator orcid:0000-0002-1468-3557;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}